European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.
Pristipino C, Germonpré P, Toni D, Sievert H, Meier B, D'Ascenzo F, Berti S, Onorato EM, Bedogni F, Mas JL, Scacciatella P, Hildick-Smith D, Gaita F, Kyrle PA, Thomson J, Derumeaux G, Sibbing D, Chessa M, Hornung M, Zamorano J, Dudek D; EVIDENCE SYNTHESIS TEAM; D'Ascenzo F, Omedè P, Ballocca F, Barbero U, Giordana F, Gili S, Iannaccone M; INTERNATIONAL EXPERTS; Akagi T, Anzola G, Carroll J, Dalvi B, Angelis C, Junbo G, Kasner SE, Michel-Behnke I, Musumeci G, Søndergaard L, Tarantini G, Biondi-Zoccai GGL; joint task force of European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Stroke Organisation (ESO), European Heart Rhythm Association (EHRA), European Association for Cardiovascular Imaging (EACVI), European Paediatric and Congenital Cardiology (AEPC), ESC Working Group on Adult Congenital Heart Disease, ESC Working Group on Thrombosis, European Haematological Society (EHA), European Underwater and Baromedical Society (EUBS); EAPCI SCIENTIFIC DOCUMENTS AND INITIATIVES COMMITTEE; Capodanno D, Valgimigli M, Byrne R, Kunadian V.
Pristipino C, et al.
Eur Heart J. 2021 Apr 21;42(16):1545-1553. doi: 10.1093/eurheartj/ehaa1070.
Eur Heart J. 2021.
PMID: 33507260